Detalles de la búsqueda
1.
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Br J Haematol
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802107
2.
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Oncologist
; 28(9): 799-803, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226534
3.
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.
BMC Med Res Methodol
; 23(1): 179, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537545
4.
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Support Care Cancer
; 31(5): 256, 2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043087
5.
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Value Health
; 25(7): 1157-1164, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779942
6.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34053112
7.
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
Am J Hematol
; 96(5): 552-560, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650179
8.
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
Clin Trials
; 18(4): 500-504, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33866856
9.
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Blood
; 130(16): 1800-1808, 2017 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28774879
10.
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.
BMC Cancer
; 19(1): 552, 2019 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31174497
11.
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes.
Clin Trials
; 16(1): 14-17, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466310
12.
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.
Blood
; 126(6): 733-8, 2015 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109202
13.
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
Can J Diabetes
; 48(3): 195-203.e1, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38211830
14.
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.
Leuk Lymphoma
; 65(5): 609-617, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235709
15.
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.
Blood
; 128(5): 732-5, 2016 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27338095
16.
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Am J Hematol
; 93(2): E49-E52, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164656
17.
A retrospective study of autologous stem cell mobilization to guide an immediate salvage protocol using plerixafor for patients who mobilize stem cells poorly.
J Clin Apher
; 28(5): 378-80, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23483573
18.
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities.
BMJ Open
; 13(8): e073353, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37567744
19.
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 23(7): 484-490, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37127473
20.
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
J Clin Oncol
; 41(25): 4164-4177, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37319384